Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate and Fludarabine in T-LGL Leukemia
NCT00278265Phase 2Terminated
- Sponsor
- German CLL Study Group
- Start
- Jun 2005
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, fludarabine in T-cell large granular lymphocytic leukemia, sponsored by German CLL Study Group. Started Jun 2005; status: terminated.
02
Drugs
methotrexatefludarabine
03
Conditions
T-cell large granular lymphocytic leukemia
Beyond the preview
Go deeper on NCT00278265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278265.